Literature DB >> 6791585

Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins.

R T Irvin, J W Govan, J A Fyfe, J W Costerton.   

Abstract

Mucoid Pseudomonas aeruginosa strains isolated from cystic fibrosis patients are very heterogeneous and include a class which is hypersusceptible to carbenicillin (minimum inhibitory concentration, less than or equal to 1 microgram/ml). Hypersusceptible mucoid P. aeruginosa isolates were found in 12 of 22 cystic fibrosis patients examined. In cystic fibrosis patients having both resistant and hypersusceptible mucoid strains, 24 of 54 mucoid colonies obtained from a sputum sample were found to belong to the hypersusceptible class. In most instances, hypersusceptible and resistant strains isolated from the same sputum sample were indistinguishable, aside from their antibiotic susceptibilities, by classical methods. A particular pair of mucoid isolates (one hypersusceptible and one resistant) was chosen for further study. The hypersusceptibility was not limited to carbenicillin but was found to extend to other penicillins, tetracycline, and trimethoprim but not to the aminoglycosides gentamicin and tobramycin. The hypersusceptibility of the mucoid strain was found to be unrelated to amount or ability to synthesize alginate. The hypersusceptible strain was found to have two additional outer membrane proteins (32,000 and 25,000 daltons) as compared with the resistant strain. The 32,000-dalton protein, termed protein N1, was found to be correlated to the hypersusceptibility phenotype, as all spontaneous mutants of the hypersusceptible mucoid strain which were capable of growing in the presence of 50 microgram of carbenicillin per ml had lost the 32,000-dalton outer membrane protein. The possible origins of the hypersusceptibility phenotype and the implications of the heterogeneity of mucoid P. aeruginosa in the pathogenesis of P. aeruginosa are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791585      PMCID: PMC181607          DOI: 10.1128/AAC.19.6.1056

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.

Authors:  J R Govan; J A Fyfe
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

2.  Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action.

Authors:  J H Luft
Journal:  Anat Rec       Date:  1971-11

3.  Outer membrane of Salmonella XIV. Reduced transmembrane diffusion rates in porin-deficient mutants.

Authors:  H Nikaido; S A Song; L Shaltiel; M Nurminen
Journal:  Biochem Biophys Res Commun       Date:  1976-05-23       Impact factor: 3.575

4.  Incidence of mucoid Pseudomonas aeruginosa from clinical sources.

Authors:  R G Doggett
Journal:  Appl Microbiol       Date:  1969-11

5.  Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.

Authors:  T W Seale; H Thirkill; M Tarpay; M Flux; O M Rennert
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

6.  Mutants of Escherichia coli "cryptic" for certain periplasmic enzymes: evidence for an alteration of the outer membrane.

Authors:  I R Beacham; D Haas; E Yagil
Journal:  J Bacteriol       Date:  1977-02       Impact factor: 3.490

7.  Outer membrane of Escherichia coli: properties of the F sex factor traT protein which is involved in surface exclusion.

Authors:  P A Manning; L Beutin; M Achtman
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

8.  Ultrastructure and adhesion properties of Ruminococcus albus.

Authors:  H Patterson; R Irvin; J W Costerton; K J Cheng
Journal:  J Bacteriol       Date:  1975-04       Impact factor: 3.490

9.  Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations.

Authors:  G F Ames; E N Spudich; H Nikaido
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  Alterations in the outer membrane of the cell envelope of heptose-deficient mutants of Escherichia coli.

Authors:  J Koplow; H Goldfine
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

View more
  22 in total

1.  Use of microfluidic technology to analyze gene expression during Staphylococcus aureus biofilm formation reveals distinct physiological niches.

Authors:  Derek E Moormeier; Jennifer L Endres; Ethan E Mann; Marat R Sadykov; Alexander R Horswill; Kelly C Rice; Paul D Fey; Kenneth W Bayles
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

2.  Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media.

Authors:  K Fonseca; J MacDougall; T L Pitt
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

3.  Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome In Vitro and in the Cystic Fibrosis Setting.

Authors:  Carla López-Causapé; Rosa Rubio; Gabriel Cabot; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 4.  Exploiting bacterial iron acquisition: siderophore conjugates.

Authors:  Cheng Ji; Raúl E Juárez-Hernández; Marvin J Miller
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

5.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Inability of purified Pseudomonas aeruginosa exopolysaccharide to bind selected antibiotics.

Authors:  C S Tannenbaum; A T Hastie; M L Higgins; F Kueppers; G Weinbaum
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

7.  Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.

Authors:  A J Godfrey; L Hatlelid; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.

Authors:  M Rella; D Haas
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

9.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Carbenicillin resistance of Pseudomonas aeruginosa.

Authors:  A Rodríguez-Tebar; F Rojo; D Dámaso; D Vázquez
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.